Disclosure from Vaping Professionals Wanted: Exciting Rewards Await!

Industry Insight by 2FIRSTS
Jan.16.2024
Disclosure from Vaping Professionals Wanted: Exciting Rewards Await!
Rewards ranging from CN¥200 to CN¥1000 for adopted releases of information. Looking forward to your participation!

To obtain first-hand industry information, 2FIRSTS is thrilled to announce the launch of a rewarding tip-off initiative starting from January 16th. We have established a dedicated mailbox to encourage professionals within the industry to share exclusive leads in exchange for attractive rewards.

 

The information you provide can include, but is not limited to, industry dynamics, market insights, unforeseen events, company developments, and more. As long as your tip meets our requirements, 2FIRSTS will promptly assign editors to follow up, ensuring that the information receives timely attention.

 

Upon verification and adoption of the tip, the informant stands a chance to receive cash rewards ranging from ¥200 to ¥1000 (amounts may vary). In case of duplicate tips, only the first informant will be eligible for the reward.

 

Terms and Conditions:

 

Time Frame: 

Effective from January 16, 2023, ongoing.

 

Reward Mechanism: 

Cash rewards ranging from ¥200 to ¥1000 for adopted tips (only the first informant will be rewarded in case of duplicate tips).

 

Tip-off Content: 

Inclusive of, but not limited to, industry dynamics, market information, unforeseen events, company movements within the electronic cigarette industry.

 

Participation Method: 

If you are a professional in the e-cigarette industry, simply send the crucial information you possess to our dedicated email address [info@2firsts.com]. We will promptly follow up on your tip.

 

Through this interactive platform, we look forward to establishing closer connections with industry professionals and collectively driving the development of the vaping industry. We appreciate everyone's continuous support for 2FIRSTS and eagerly await your active participation in creating more enriching and accurate industry content!

 

2FIRSTS Editorial Department

 


About 2FIRSTS

 

Established in early 2022, 2FIRSTS is a globally influential aerosol technology media and think tank. Our core readership includes regulatory authorities from various countries, international new tobacco companies, distributors, supply chain enterprises, non-profit organizations, and media outlets. 2FIRSTS brings readers the latest global information, forward-thinking topics, in-depth analyses, insights, and rich data and information. We are committed to promoting high-quality development of the global new tobacco industry through media and research, contributing to harm reduction initiatives worldwide.

 

2FIRSTS has currently established platforms such as 2firsts.cn (Chinese), 2firsts.com (International), and 2firsts.com/es (Spanish), with a daily visitation exceeding 10,000.

 

With offices in Shenzhen, Hong Kong, New York, Europe, and collaborations with international new tobacco companies, regulatory authorities, and media outlets, 2FIRSTS maintains excellent cooperation and close communication. We are also proud partners and official media representatives for major global new tobacco exhibitions.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20